Study: Bypass patients outlive those getting stents; Torax gets FDA OK for GERD device;

@FierceMedDev: Biomet had previous run-in with feds | The Journal Gazette | Fort Wayne, IN. Item | Follow @FierceMedDev

> Data from a large study show patients with blocked coronary arteries choosing heart bypass surgery over a less-invasive stent procedure appear to live longer. In fact, 20.8% of patients who had an angioplasty procedure died in the first four years after treatment. The death rate for bypass patients after four years was 16.4%. Article

> Torax Medical has received the FDA's blessing for its LINX reflux management system for use in patients diagnosed with gastroesophageal reflux disease. Torax release

> A new microdevice could provide insights into disorders and help evaluate potential treatments of the intestine. The gut-on-a-chip mimics complex 3-D features of the intestine in a miniaturized form, according to Wyss Institute researchers. Wyss Institute release

> The American Federation of State, County and Municipal Employees is recommending that shareholders of Johnson & Johnson ($JNJ) vote against the ratification of executive compensation at the company's annual meeting to be held April 26. The union cites ongoing problems with recalls and litigation as reasons for the no vote. AFSCME release

> Results from an AliveCor study demonstrated how the company's ECG monitoring device allows users to learn and characterize their heart rates by using the hand-held device in their hands or on their chest. AliveCor release

> Becton, Dickinson ($BDX) and the Foundation for Innovative New Diagnostics are collaborating to promote access to early and accurate diagnosis of multidrug-resistant tuberculosis among HIV-infected patients and other vulnerable populations in India. Release

> A new syringe design could eliminate shot-related pain by using two separate needles working in quick succession. Report

And Finally... Former Olympus CEO Michael Woodford may have been ousted from his company--which makes endoscopes (among other things)--after trying to publicly disclose an accounting scandal, but he's not remaining quiet. He's writing books, giving speeches ... and a movie deal isn't out of the question. Story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.